Allethrin Scabies

24 Hour Natural Scabies Remedy Report

Scabies 24 Hour Natural Remedy

Get Instant Access

1. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003; 189:S24.

2. McKay M. Dysesthetic ("essential") vulvodynia. Treatment with amitriptyline. J Reprod Med 1993; 38:9.

3. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003; 102:84.

4. Haefner HK et al. The vulvodynia guideline. J Low Genit Tract Dis 2005; 9:40.

5. Gerber S et al. Topical cytokine cream for vulvar vestibulitis. Poster presented at: Vulvodynia and Sexual Pain Disorders: a State of the Art Consensus Conference, Atlanta, GA, Oct 2004.

6. Bergeron S et al. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther 2002; 28:183.

7. Marinoff SC et al. Intralesional alpha interferon. Cost-effective therapy for vulvar vestibulitis syndrome. J Reprod Med 1993; 38:19.

8. Bornstein J et al. A pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment. Gynecol Obstet Invest 2000; 50:194.

9. Haefner HK. Critique of new gynecologic surgical procedures: surgery for vulvar vestibulitis. Clin Obstet Gynecol 2000; 43:689.

10. Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med 1991; 36:879.

11. Farage MA, Maibach HI. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures. Contact Dermatitis 2004; 51:201.

12. Welsh BM et al. Management of common vulval conditions. Med J Aust 2003; 178:391.

13. Foster D. Vulvar disease. Obstet Gynecol 2002; 100:145.

14. Cheer S, Plosker G. Tacrolimus ointment: a review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2:389.

15. Meurer M et al. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002; 205:271.

16. Wakelin S, Maibach HI. Handbook of Systemic Drug Treatment in Dermatology. London: Manson Publishing, Ltd., 2002.

17. Meggit S, Reynolds N. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001; 26:369.

18. McKay M. Vulvar manifestations of skin disorders. In: Black M, McKay M et al., eds. Obstetric and Gynecologic Dermatology. London: Mosby, 2002.

Dalziel K, Millard PR, Wojnarowska F. The treatment of vulvar lichen sclerosus with a very potent topical corticosteroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124:4614.

Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998; 43:7904.

Bracco G et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. J Reprod Med 1993; 38:40.

Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: an overview. Br J Dermatol 1998; 139:7636.

Sinha P, Sorinola O, Luesley DM. Lichen sclerosus of the vulva. Long-term steroid maintenance therapy. J Reprod Med 1999; 44:621.

Mazdisnian F et al. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med 1999; 44:332.

Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991; 78:1046.

Sideri M et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynecol Obstet 1994; 46:536.

Abramov Y et al. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996; 51:193.

August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophi-cus of the vulva. Br J Dermatol 1980; 103:667.

Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136:356.

Hillemans P et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminole-vulinic acid. Obstet Gynecol 1999; 93:714.

Bousema MT et al. Acitretin in the treatment of lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30:225.

Virgili A et al. Open study of topical 0.025% tretinoin in the treatment of vulval lichen sclerosus. One year of therapy. J Reprod Med 1995; 40:614. Kreuter A et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26:30.

Reichrath J, Reinhold U, Tilgen W. Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy: an open pilot study in 12 patients. Dermatology 205:245.

Kunstfeld R et al. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139:850.

Bohm M et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139:922.

Wallace HJ. Lichen sclerosus et atrophicus. Trans Rep St. Johns Hosp Dermatol Soc 1971; 57:9.

Lewis F. Vulval lichen planus. Br J Dermatol 1998; 138:569.

Anderson M, Kutzner SM, Kaufman RH. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories. Obstet Gynecol 2002; 100:359.

Edwards L. Vulvar lichen planus. Arch Dermatol 1989; 125:1677.

Lotery H, Galask R. Erosive lichen planus of the vulva and vagina. Obstet Gynecol

2003; 101:1121.

42. Byrd J, Davis M, Rogers R. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol 2004; 140:715.

43. Larrabee R, Kylander D. Benign vulvar disorders. Identifying features, practical management of nonneoplastic conditions and tumors. Postgrad Med 2001; 109:151.

44. Omole F, Simmons BJ, Hacker Y. Management of Bartholin's duct cyst and gland abscess. Am Fam Physician 2003; 68:135.

45. Miller NR. Sepsis after Bartholin's duct abscess marsupialization in a gravida. J Reprod Med 2001; 46:913.

46. Gallup D et al. Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency. Am J Obstet Gynecol 2002; 187:305.

47. Workowski KA et al. U.S. Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice. Ann Intern Med 2002; 137:255.

48. Hook EW et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29:486.

49. Lukehart S et al. Macrolide resistance in treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351:154.

50. World Health Organization. Guidelines for the management of sexually transmitted infections, 2003. Available at: 9241546263.pdf. Accessed Sept 21, 2005.

51. Martin D et al. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 1995; 21:409.

52. Brown D Jr et al. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis: comparison with miconazole nitrate and placebo. J Reprod Med 1986; 31:1045.

53. Brown D et al. Butoconazole nitrate 2% for vulvovaginal candidiasis. J Reprod Med 1999; 44:933.

54. Lebherz T et al. A comparison study of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use. Clin Ther 1983; 5:409.

55. Franklin R. Seven-day clotrimazole therapy for vulvovaginal candidiasis. South Med J 1978; 71:141.

56. Sobel JD et al. The fluconazole vaginitis study group, single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol 1995; 172:1263.

57. Goode MA et al. Single dose fluconazole versus clotrimazole in the treatment of vaginal candidiasis. International Pharmaceutical Abstracts (ASHP Midyear Clinical Meeting) 1992; 27:61.

58. Stein GE et al. Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis. Antimicrob Agents Chemother 1986; 29:969.

59. Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med 1992; 68:36.

60. Woolley PD. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract 1995; 49:65.

61. Fleury F, Hodgson C. Single-dose treatment of vulvovaginal candidiasis with a new 500 mg clotrimazole vaginal tablet. Adv Ther 1984; 1:349.

62. Guess EA, Hodgson C. Single-dose topical treatment of vulvovaginal candidiasis with a new 500 mg clotrimazole vaginal tablet. Adv Ther 1984; 1:137.

63. Adetoro OO. Comparative trial of a single dose of fluconazole (150 mg) and a single intravaginal tablet of clotrimazole (500 mg) in the treatment of vaginal candidiasis. Curr Ther Res 1990; 48:275.

64. Boag FC et al. Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis. Genitourin Med 1991; 67:232.

65. Van Heusden AM et al. A randomized, comparative study of a single oral dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists. Eur J Obstet Gynaecol Reprod Biol 1994; 55:123.

66. Thomason JL et al. Terconazole for the treatment of vulvovaginal candidiasis. J Reprod Med 1990; 35:992.

67. Isaacs JH. Nystatin vaginal cream in monilial vaginitis. Illinois Med J 1973; 3:240.

68. Clark C et al. A multicenter comparison of one-dose tioconazole ointment with three-dose terconazole cream in vulvovaginal candidiasis. J Womens Hlth 1993; 2:189.

69. Palacio-Hernanz A, Sanz-Sanz F, Rodriquez-Noriega A. Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis. Chemioterapia 1984; 3:192.

70. Slavin MB et al. Single dose oral fluconazole vs intravaginal terconazole in treatment of candida vaginitis. J Florida Med Assoc 1992; 79:693.

71. Sobel JD. Vaginitis. N Engl J Med 1997; 337:1896.

72. Sobel J et al. Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998; 178:203.

73. Spence D. Candidiasis (vulvovaginal). Clin Evid 2004; 12:2490.

74. Watson MC, Grimshaw JM, Bond CM et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2001; CD008245.

75. Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother 1993; 37:89.

76. Fife KH et al. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: results of an international, multicenter, double-blind randomized clinical trial. Sex Transm Dis 1997; 24:481.

77. Loveless M, Harris W, Sacks S. Treatment of first episode genital herpes with famciclovir, Programs and Abstracts of the 35th Interscience Conference on Anitmicrobial Agents and Chemotherapy, San Francisco, Sept 17-20, 1995, Abstract A12.

78. Mertz G et al. Double-blind placebo-controlled trial of oral acyclovir in the first episode genital herpes simplex virus infection. J Am Med Assoc 1984; 252:1147.

79. Jungmann E. Genital herpes. Clin Evid 2004; 11:2073.

80. Stone K, Whittington W. Treatment of genital herpes. Rev Infect Dis 1990; 12:610.

81. Wald A et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002; 34:944.

82. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis 1999; 28:S4.

83. Strand A et al. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir. Sex Transm Infect 2002; 78:435.

84. Wald A et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997; 99:1092.

85. Dupin N. Treatment of genital warts. Clin Dermatol 2004; 22:48.

86. Buck H. Genital warts. Clin Evid 2004; 12:1.

87. Beutner K et al. Patient-applied podofilox for treatment of genital warts. Lancet 1989; 1:831.

88. Edwards L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134:25.

89. Moore R et al. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001; 1:3.

90. Stone KM et al. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 1990; 66:16.

91. Duus B et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 1985; 61:59.

92. Gross G et al. Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation—influence of the cyclic low-close therapy regime. Genitourin Med 1996; 76:71.

93. Gross G et al. Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double blind study in 120 patients. Dermatology 1998; 196:330.

94. Snoeck R et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis 2001; 33:597.

95. Matteelli A. Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons. Sex Transm Dis 2001; 28:343.

96. Orlando G et al. Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients. AIDS 2002; 16:447.

97. Krebs HB. Treatment of extensive vulvar condylomata acuminata with topical 5-fluorouracil. South Med J 1990; 83:761.

98. Swinehart JM et al. Development of intralesional therapy with fluorouracil/ adrenaline injectable gel for management of condylomata acuminata: two phase II clinical studies. Genitourin Med 1997; 73:481.

99. Ting P, Dytoc M. Therapy of external anogenital warts and molluscum contagiosum: a literature review. Dermatol Ther 2004; 17:68.

100. Amstey MS, Trombetta GC. Laser therapy for vulvar molluscum contagiosum infection. Am J Obstet Gynecol 1985; 153:800.

101. Friedman M, Gal D. Keloid scars as a result of CO2 laser for molluscum contagio-sum. Obstet Gynecol 1987; 70:394.

102. Brown T, Yen-Moore A, Tyring S. An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol 2001; 357:661.

103. Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatol 1994; 189:65.

104. Hengge UR et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143:1026.

105. Liota E et al. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 2000; 4:76.

106. De Clercq E, Neyts J. Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections. Rev Med Virol 2004; 14:289.

107. Tuzun B et al. Anogenital lesions (viral diseases and ectoparasitic infestations): unapproved treatments. Clin Dermatol 2002; 20:668.

108. Zabawski EJ Jr, Cockerell CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J Am Acad Dermatol 1998; 39:741.

109. Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2000; 2:CD000320.

110. Schultz MW et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990; 126:167.

111. Amer M, El-Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int J Dermatol 1992; 31:357.

112. Taplin D et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7:67.

113. Hansen RC, Remmers E, Menter MA. A controlled comparative trial of permethrin 5 per cent cream and 1 per cent lindane lotion for the treatment of scabies. Clin Res 1986; 34:160.

114. Schultz MW et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990; 126:167.

115. Taplin D et al. Permethrin 5% dermal cream: a new treatment for scabies. J Am Acad Dermatol 1986; 15:995.

116. Chouela EN et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135:651.

117. Glaziou P et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44:331.

118. Gulati PV, Singh KP. A family based study on the treatment of scabies with benzyl benzoate and sulphur ointment. Indian J Dermatol Venereol Leprol 1978; 44:269.

119. Orkin M, Maibach HI. Scabies and pediculosis. In: Freedberg IM, Eisen AZ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill Publishing, 1999:2677.

120. Orion O, Matz H, Wolf R. Ectoparasitic sexually transmitted diseases: scabies and pediculosis. Clin Dermatol 2004; 22:513.

121. McLeod WA. Acute lindane poisoning (letter). Can Med Assoc J 1978; 118:123.

122. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Safety 196; 14:386.

123. Rauch AE et al. Gamma benzene hexachloride (Kwell) induced aplastic anemia. Arch Intern Med 1990; 150:2393.

124. Ramussen JE. The problem of lindane. J Am Acad Dermatol 1981; 5:507.

125. U.S. Food and Drug Administration, FDA Talk Paper, FDA issues health advisory regarding labeling changes for lindane products. Available at: bbs/topics/ANSWERS/2003/ANS01205.html. Accessed Sept 21, 2005.

126. Chosidow O. Scabies and pediculosis. Lancet 2000; 355:819.

127. Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J 2005; 81:7.

128. Roth WI. Scabies resistant to lindane 1% lotion and crotamiton 10% cream. J Am Acad Dermatol 1991; 24:502.

129. Meinking T et al. The treatment of scabies with ivermectin. N Engl J Med 1995; 333:26.

130. Vaidhyanathan U. Review of ivermectin in scabies. J Cutan Med Surg 2001; 5:496.

131. Macotela-Ruiz E, Islas CCM, Ramos N. Tratamiento de escabiasis con Ivermectina por via oral en una comunidad rural cerrada. Implicaciones epidemiologicas. Dermatologica Rev Mex 1996; 40:179.

132. Dunne CL, Malone CJ, Whiworth JAG. A field study of the effects of ivermectin on ectoparasites of man. Trans R Soc Trop Med Hyg 1991; 85:550.

133. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349:1144.

134. Paasch U, Haustein U. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000; 39:463.

135. Gulati PV, Singh KP. A family based study on the treatment of scabies with benzyl benzoate and sulphur ointment. Indian J Dermatol Venereol Leprolo 1978; 44:269.

136. Ko CJ, Elston DM. Pediculosis. J Am Acad Dermatol 2004; 50:1.

137. Joura EA. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol 2002; 14:39.

138. Ferenczy A, Wright TC Jr, Richart RM, Comparison of CO2 laser surgery and loop electrosurgical excision/fulguration procedure (LEEP) for the treatment of vulvar intraepithelial neoplasia (VIN). Int J Gynecol Cancer 1994; 4:22.

139. Tyring S. Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment. Am J Obstet Gynecol 2003; 189:S17.

140. Kelley J et al. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol 1992; 44:240.

141. Stehman F et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992; 79:490.

142. Keys H. Gynecologic Oncology Group randomized trials of combined technique therapy for vulvar cancer. Cancer 1993; 71:1691.

143. Spirtos NM, Smith LH, Teng NN. Prospective randomized trial of topical alphainterferon (alpha-interferon gels) for the treatment of vulvar intraepithelial neoplasia III. Gynecol Oncol 1990; 37:34.

144. Fehr MK et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol 2001; 80:62.

145. Berek JM et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991; 42:197.

146. Moore D et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42:79.

147. National Cancer Institute. Vulvar cancer (PDQ) treatment. Available at: http:// Accessed Sept 21, 2005.

148. Jayne CJ, Kaufman RH. Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod. J Reprod Med 2002; 47:395.

149. Thuis YN et al. Contemporary experience with the management of vulvar intraepithelial neoplasia. Int J Gynecol Cancer 2000; 10:223.

150. Herod J et al. Vulvar intraepithelial neoplasia: long term follow up treated and untreated. Br J Obstet Gynaecol 1996; 103:446.

151. Sideri M et al. Evaluation of CO2 laser excision or vaporization for the treatment of vulvar intraepithelial neoplasia. Gynecol Oncol 1999; 75:277.

152. Vlastos A et al. Loop electrosurgical excision procedure in vulvar intraepithelial neoplasia treatment. J Lower Gen Tract Dis 2002; 6:232.

153. Marren OM et al. Failure of cryosurgery to eradicate vulval intraepithelial neoplasia: a pilot study. J Eur Acad Dermatol Venereol 1993; 2:247.

154. Grendys EC Jr, Fiorica JV. Innovations in the management of vulvar carcinoma. Curr Opin Obstet Gynecol 2000; 12:15.

155. Farias-Eisner FD et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994; 53:55.

156. Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000; CD002036.

157. Burke TW et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995; 57:215.

158. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979; 133:825.

159. Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer 1993; 71:1673.

160. Andreasson B et al. Verrucous carcinoma of the vulval region. Acta Obstet Gynecol Scand 1983; 62:183.

161. Shepherd V, Davidson E, Davies-Humphreys J. Extramammary Paget's disease. BJOG 2005; 112:273.

Was this article helpful?

0 0
Bacterial Vaginosis Facts

Bacterial Vaginosis Facts

This fact sheet is designed to provide you with information on Bacterial Vaginosis. Bacterial vaginosis is an abnormal vaginal condition that is characterized by vaginal discharge and results from an overgrowth of atypical bacteria in the vagina.

Get My Free Ebook

Post a comment